Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 39.86 Million USD | 37.46% |
| 2022 | 29 Million USD | 8.25% |
| 2021 | 26.79 Million USD | 15.22% |
| 2020 | 23.25 Million USD | 19.31% |
| 2019 | 19.49 Million USD | 43.95% |
| 2018 | 13.53 Million USD | -6.35% |
| 2017 | 14.45 Million USD | 15.37% |
| 2016 | 12.53 Million USD | 15.9% |
| 2015 | 10.81 Million USD | -27.71% |
| 2014 | 14.95 Million USD | 14.49% |
| 2013 | 13.06 Million USD | 28.32% |
| 2012 | 10.18 Million USD | 57.98% |
| 2011 | 6.44 Million USD | 8.18% |
| 2010 | 5.95 Million USD | -22.71% |
| 2009 | 7.7 Million USD | -30.62% |
| 2008 | 11.1 Million USD | 57.31% |
| 2007 | 7.06 Million USD | 285.27% |
| 2006 | 1.83 Million USD | 0.0% |
| 2005 | - USD | 100.0% |
| 2004 | -4.53 Million USD | 20.97% |
| 2003 | -5.73 Million USD | -98.89% |
| 2002 | -2.88 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 36.29 Million USD | -8.96% |
| 2024 Q3 | 36.53 Million USD | 0.68% |
| 2024 Q1 | 39.86 Million USD | -0.02% |
| 2023 Q4 | 39.86 Million USD | -6.55% |
| 2023 FY | 39.86 Million USD | 37.46% |
| 2023 Q1 | 36.61 Million USD | 26.24% |
| 2023 Q3 | 42.66 Million USD | 5.06% |
| 2023 Q2 | 40.6 Million USD | 10.91% |
| 2022 Q4 | 29 Million USD | 2.38% |
| 2022 FY | 29 Million USD | 8.25% |
| 2022 Q2 | 27.75 Million USD | -2.68% |
| 2022 Q1 | 28.52 Million USD | 6.45% |
| 2022 Q3 | 28.32 Million USD | 2.06% |
| 2021 Q2 | 31.25 Million USD | 28.7% |
| 2021 Q3 | 29.42 Million USD | -5.87% |
| 2021 Q4 | 26.79 Million USD | -8.93% |
| 2021 FY | 26.79 Million USD | 15.22% |
| 2021 Q1 | 24.28 Million USD | 4.43% |
| 2020 Q4 | 23.25 Million USD | 19.5% |
| 2020 Q2 | 18.42 Million USD | -15.03% |
| 2020 Q1 | 21.68 Million USD | 11.26% |
| 2020 FY | 23.25 Million USD | 19.31% |
| 2020 Q3 | 19.46 Million USD | 5.62% |
| 2019 Q4 | 19.49 Million USD | -6.77% |
| 2019 FY | 19.49 Million USD | 43.95% |
| 2019 Q1 | 15.77 Million USD | 16.54% |
| 2019 Q3 | 20.9 Million USD | 19.83% |
| 2019 Q2 | 17.44 Million USD | 10.58% |
| 2018 Q3 | 13.32 Million USD | 3.03% |
| 2018 Q2 | 12.93 Million USD | -1.79% |
| 2018 Q1 | 13.16 Million USD | -8.94% |
| 2018 FY | 13.53 Million USD | -6.35% |
| 2018 Q4 | 13.53 Million USD | 1.63% |
| 2017 Q1 | 12.91 Million USD | 3.1% |
| 2017 FY | 14.45 Million USD | 15.37% |
| 2017 Q4 | 14.45 Million USD | 1.45% |
| 2017 Q3 | 14.25 Million USD | 16.68% |
| 2017 Q2 | 12.21 Million USD | -5.46% |
| 2016 Q2 | 12.11 Million USD | 7.61% |
| 2016 FY | 12.53 Million USD | 15.9% |
| 2016 Q3 | 12.2 Million USD | 0.75% |
| 2016 Q4 | 12.53 Million USD | 2.7% |
| 2016 Q1 | 11.25 Million USD | 4.1% |
| 2015 Q1 | 16.1 Million USD | 7.71% |
| 2015 Q4 | 10.81 Million USD | -15.81% |
| 2015 Q3 | 12.84 Million USD | -6.13% |
| 2015 Q2 | 13.68 Million USD | -15.07% |
| 2015 FY | 10.81 Million USD | -27.71% |
| 2014 Q1 | 11.3 Million USD | -13.44% |
| 2014 Q4 | 14.95 Million USD | 10.76% |
| 2014 FY | 14.95 Million USD | 14.49% |
| 2014 Q2 | 13.37 Million USD | 18.31% |
| 2014 Q3 | 13.5 Million USD | 0.94% |
| 2013 Q3 | 12.68 Million USD | -0.6% |
| 2013 Q4 | 13.06 Million USD | 2.97% |
| 2013 FY | 13.06 Million USD | 28.32% |
| 2013 Q1 | 11.75 Million USD | 15.48% |
| 2013 Q2 | 12.76 Million USD | 8.56% |
| 2012 FY | 10.18 Million USD | 57.98% |
| 2012 Q4 | 10.18 Million USD | 5.14% |
| 2012 Q3 | 9.68 Million USD | 3.3% |
| 2012 Q2 | 9.37 Million USD | 5.28% |
| 2012 Q1 | 8.9 Million USD | 38.16% |
| 2011 Q3 | 9.59 Million USD | -3.78% |
| 2011 Q4 | 6.44 Million USD | -32.81% |
| 2011 Q2 | 9.96 Million USD | 9.23% |
| 2011 Q1 | 9.12 Million USD | 53.2% |
| 2011 FY | 6.44 Million USD | 8.18% |
| 2010 FY | 5.95 Million USD | -22.71% |
| 2010 Q3 | 7.33 Million USD | 17.03% |
| 2010 Q4 | 5.95 Million USD | -18.78% |
| 2010 Q2 | 6.26 Million USD | -8.4% |
| 2010 Q1 | 6.84 Million USD | -11.22% |
| 2009 FY | 7.7 Million USD | -30.62% |
| 2009 Q1 | 11.1 Million USD | -0.04% |
| 2009 Q3 | 8.35 Million USD | -14.36% |
| 2009 Q4 | 7.7 Million USD | -7.74% |
| 2009 Q2 | 9.75 Million USD | -12.16% |
| 2008 Q3 | 10.3 Million USD | -14.04% |
| 2008 FY | 11.1 Million USD | 57.31% |
| 2008 Q2 | 11.99 Million USD | 25.92% |
| 2008 Q4 | 11.1 Million USD | 7.77% |
| 2008 Q1 | 9.52 Million USD | 34.85% |
| 2007 FY | 7.06 Million USD | 285.27% |
| 2007 Q3 | 3.94 Million USD | -3.59% |
| 2007 Q4 | 7.06 Million USD | 79.1% |
| 2007 Q2 | 4.09 Million USD | 58.71% |
| 2007 Q1 | 2.57 Million USD | 40.59% |
| 2006 Q1 | 2.06 Million USD | 0.0% |
| 2006 Q2 | 1.89 Million USD | -8.32% |
| 2006 Q3 | 1.83 Million USD | -3.16% |
| 2006 Q4 | 1.83 Million USD | -0.16% |
| 2006 FY | 1.83 Million USD | 0.0% |
| 2005 Q4 | - USD | 100.0% |
| 2005 Q3 | -5.23 Million USD | -17.42% |
| 2005 FY | - USD | 100.0% |
| 2005 Q1 | -4.53 Million USD | 0.0% |
| 2005 Q2 | -4.46 Million USD | 1.61% |
| 2004 Q3 | -4.6 Million USD | 23.72% |
| 2004 Q4 | -4.53 Million USD | 1.52% |
| 2004 Q2 | -6.03 Million USD | 17.49% |
| 2004 Q1 | -7.31 Million USD | -27.49% |
| 2004 FY | -4.53 Million USD | 20.97% |
| 2003 FY | -5.73 Million USD | -98.89% |
| 2003 Q3 | -4.68 Million USD | -9.17% |
| 2003 Q4 | -5.73 Million USD | -22.56% |
| 2003 Q2 | -4.28 Million USD | -13.89% |
| 2003 Q1 | -3.76 Million USD | -30.51% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | -2.88 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | -2.88 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -1104.471% |
| BrainsWay Ltd. | 3.71 Million USD | -972.585% |
| Envoy Medical, Inc. | 1.4 Million USD | -2739.601% |
| electroCore, Inc. | 2.16 Million USD | -1745.741% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -8623.851% |
| IceCure Medical Ltd | 2.27 Million USD | -1652.44% |
| Inogen, Inc. | 21.84 Million USD | -82.546% |
| OrthoPediatrics Corp. | 105.85 Million USD | 62.336% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -14241.007% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -3986799900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -226.012% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -2208.932% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -25387.789% |
| Orthofix Medical Inc. | 222.16 Million USD | 82.055% |
| PAVmed Inc | 1.01 Million USD | -3820.161% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -99.729% |
| RxSight, Inc. | 17.42 Million USD | -128.85% |
| Sight Sciences, Inc. | 7.84 Million USD | -407.937% |
| SI-BONE, Inc. | 20.24 Million USD | -96.889% |
| TELA Bio, Inc. | 13.16 Million USD | -202.902% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -36.324% |
| Vivos Therapeutics, Inc. | 1.00 USD | -3986799900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -831.931% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -17233.913% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -1592.19% |
| CVRx, Inc. | 10.98 Million USD | -262.997% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -10120.572% |
| Bioventus Inc. | 91.33 Million USD | 56.349% |
| Venus Concept Inc. | 28.67 Million USD | -39.029% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -1466.523% |
| LivaNova PLC | 147.88 Million USD | 73.042% |
| 908 Devices Inc. | 14.93 Million USD | -166.89% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 70.866% |
| Nemaura Medical Inc. | 1.75 Million USD | -2171.872% |
| NeuroPace, Inc. | 11.21 Million USD | -255.52% |
| LENSAR, Inc. | 15.68 Million USD | -154.114% |
| Apyx Medical Corporation | 9.92 Million USD | -301.774% |
| Cutera, Inc. | 72.1 Million USD | 44.705% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -1391.508% |
| BioSig Technologies, Inc. | -103 Thousand USD | 38806.796% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 14.052% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -403.957% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 89.767% |
| Axonics, Inc. | 79.94 Million USD | 50.128% |
| Outset Medical, Inc. | 49.21 Million USD | 18.992% |
| IRIDEX Corporation | 9.9 Million USD | -302.463% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -0.282% |
| IRadimed Corporation | 12.82 Million USD | -210.954% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -5173.545% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -14972.569% |
| Telesis Bio, Inc. | 4.02 Million USD | -890.509% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -765.882% |
| Varex Imaging Corporation | 277.5 Million USD | 85.633% |
| Quipt Home Medical Corp. | 18.32 Million USD | -117.552% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -138.117% |
| Dynatronics Corporation | 5.59 Million USD | -612.695% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -965.704% |
| Semler Scientific, Inc. | 445 Thousand USD | -8859.101% |
| InMode Ltd. | 45.09 Million USD | 11.591% |
| Bruker Corporation | 968.3 Million USD | 95.883% |
| Cytosorbents Corporation | 3.68 Million USD | -983.332% |
| DexCom, Inc. | 559.6 Million USD | 92.876% |
| Align Technology, Inc. | 296.9 Million USD | 86.572% |
| Viveve Medical, Inc. | 1.47 Million USD | -2608.424% |
| ZimVie Inc. | 79.6 Million USD | 49.915% |
| Movano Inc. | 1.51 Million USD | -2535.03% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 34.511% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -25387.789% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 74.757% |
| Profound Medical Corp. | 6.95 Million USD | -473.373% |
| Insulet Corporation | 402.6 Million USD | 90.097% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -168.67% |
| iCAD, Inc. | 917 Thousand USD | -4247.655% |
| Nuwellis, Inc. | 1.99 Million USD | -1896.395% |
| Biotricity, Inc. | 1.87 Million USD | -2021.313% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -185.322% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -1793.067% |
| PAVmed Inc. | 1.01 Million USD | -3820.161% |
| BIOLASE, Inc. | 11.43 Million USD | -248.71% |
| Beyond Air, Inc. | 2.12 Million USD | -1774.377% |
| FONAR Corporation | 2.71 Million USD | -1368.196% |
| AxoGen, Inc. | 23.02 Million USD | -73.189% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -76.979% |
| Inari Medical, Inc. | 42.9 Million USD | 7.068% |
| UFP Technologies, Inc. | 70.19 Million USD | 43.201% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -6236.512% |
| Tenon Medical, Inc. | 554 Thousand USD | -7096.39% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -2294.87% |
| AdaptHealth Corp. | 113.64 Million USD | 64.918% |
| Sintx Technologies, Inc. | 888 Thousand USD | -4389.64% |
| NanoVibronix, Inc. | 2.73 Million USD | -1359.297% |
| Quanterix Corporation | 22.36 Million USD | -78.261% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -168.526% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 29.656% |
| TransMedics Group, Inc. | 44.23 Million USD | 9.872% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -605.254% |
| NeuroMetrix, Inc. | 1.55 Million USD | -2456.578% |
| Hyperfine, Inc. | 6.58 Million USD | -505.713% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 50.127% |
| Biomerica, Inc. | 2.37 Million USD | -1577.946% |
| Bone Biologics Corporation | -328.84 Thousand USD | 12223.682% |
| AVITA Medical, Inc. | 3.12 Million USD | -1177.242% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -33.445% |